DEA approvals could unlock tax benefits for Washington medical marijuana businesses
Potential federal rescheduling opens door to Section 280E tax relief for state-licensed medical cannabis operators.
FILE — statehouse · B.D. Gilfry / CC BY-SA 2.0According to WTOP News, DEA approvals could bring tax benefits to Washington's medical marijuana businesses. The timing aligns with Washington state's October regulatory adjustments to comply with federal rescheduling, per MJBizDaily, suggesting the state has already begun positioning operators for potential federal relief.
Section 280E of the Internal Revenue Code has historically barred cannabis businesses from deducting ordinary operating expenses. A lower federal schedule classification could allow medical operators to claim standard business deductions—a significant cost reduction for licensed producers and retailers. Washington currently operates 482 retail locations, 973 cultivation facilities, and 1,009 manufacturing licenses, per state records.
Watch whether the Washington Liquor & Cannabis Board issues formal guidance on federal tax compliance for medical licensees, and whether operators begin filing amended returns claiming prior-year deductions tied to rescheduling approval dates.
Original report: WTOP News ↗